Cancer Vaccines: Novel Approaches and New Promise
- 28 February 1999
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 81 (2), 121-139
- https://doi.org/10.1016/s0163-7258(98)00039-4
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Priming of T cells by heat shock protein–peptide complexes as the basis of tumor vaccinesSeminars in Immunology, 1997
- Nomenclature for Factors of the HLA System, 1996Human Immunology, 1997
- Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8Human Immunology, 1997
- A tyrosinase nonapeptide presented by HLA‐B44 is recognized on a human melanoma by autologous cytolytic T lymphocytesEuropean Journal of Immunology, 1996
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Expression of mage genes in transitional‐cell carcinomas of the urinary bladderInternational Journal of Cancer, 1995
- Structure, chromosomal localization, and expression of 12 genes of the MAGE familyImmunogenetics, 1994
- Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cellsNature, 1993
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983